Skip to content
healthcare.dev

AMONDYS 45

NDC 60923-227, casimersen, injection, from Sarepta Therapeutics, Inc..

Product NDC
60923-227
Status
Listed
Labeler
Sarepta Therapeutics, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213026
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60923-227 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CASIMERSEN50 mg/mL

Pharmacologic classes

Antisense Oligonucleotide [EPC]; Increased Protein Synthesis [PE]; Oligonucleotides, Antisense [CS]

Package NDCNDC-11Package
60923-227-02609230227021 VIAL, SINGLE-USE in 1 CARTON (60923-227-02) / 2 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e9e5fd44-eeda-4580-bba1-a734828bbcc3

Use it

Look up 60923-227 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60923-227 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60923-227. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.